22. 3. 2018

The Power of Synergy

2 min. read

Under the auspices of the Slovenian Society of Cardiology, the international symposium The Power of Synergy was held in Novo mesto on Friday, 23 March. Around 100 top cardiologists from 16 European countries discussed the challenges and opportunities for concomitant treatment of high cholesterol and blood pressure levels. The symposium was organised as interactive lectures and workshops, focusing on patient cases from clinical practice, both in primary and secondary prevention of cardiovascular diseases.

The symposium was attended by approx. 100 top cardiologists from 16 European countries.

Krka’s portfolio includes a wide range of medicines for the treatment of elevated blood pressure and cholesterol levels, enabling the treatment to be adapted to the needs of individual patients. Several fixed-dose combinations of various active substances are available for lowering high blood pressure. The newest solution includes fixed-dose combinations of active substances, which enable concomitant treatment of elevated cholesterol and blood pressure levels by taking just one tablet a day. We were the first in Europe to offer the fixed-dose combination of rosuvastatin and amlodipine. This year, we extended our portfolio with the fixed-dose combination of rosuvastatin and valsartan and we continue to invest in developing new fixed-dose combinations. These medicines help improve patient compliance and prevent many cardiovascular events.

2/3

Prof. Mišo Šabovič (Slovenia), Breda Barbič-Žagar, medicinska direktorica (Krka), Prof. Zlatko Fras (Slovenia), Prof. Ian M. Graham (Ireland), Assist. Prof. Goran Krstačić (Croatia), Honorary Prof. Zoltán Járai (Hungary), Elizabeta Suhadolc, Director of Marketing (Krka), Prof. Krzysztof J. Filipiak (Poland), Prof. Michal Vrablík (Czech Republic), Prof. Gheorghe-Andrei Dan (Romania), Prof. Andrey V. Susekov (Russia), Prof. Marius Miglinas (Lithuania), Prof. Krzysztof Narkiewicz (Poland)